ESSA Pharma Inc. logo

ESSA Pharma Inc.

NASDAQ:EPIX

Overview | Financials
Company Name ESSA Pharma Inc.
Symbol EPIX
Currency USD
Price 5.11
Market Cap 226,694,879
Dividend Yield 0%
52-week-range 2.58 - 11.67
Industry Biotechnology
Sector Healthcare
CEO Dr. David Ross Parkinson M.D.
Website https://www.essapharma.com

An error occurred while fetching data.

About ESSA Pharma Inc.

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements

Related Stocks

AC Immune SA logo

AC Immune SA

ACIU

3.53 USD

Precigen, Inc. logo

Precigen, Inc.

PGEN

1.635 USD

Alpine Immune Sciences, Inc. logo

Alpine Immune Sciences, Inc.

ALPN

64.97 USD

Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc.

TNYA

3.8 USD

AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc.

ANTX

2.65 USD

Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc.

DYN

43.75 USD

Financials

Numbers are in millions USD

Numbers are in millions USD